Why the study?
Carotid atherosclerosis is increasingly prevalent among hypertensive patients, prompting the need for a predictive nomogram in this population.
Can a nomogram based on LASSO-logistic regression accurately predict carotid atherosclerosis in patients with hypertension?
Can a nomogram based on LASSO-logistic regression accurately predict carotid atherosclerosis in patients with hypertension?
A newly developed nomogram based on LASSO-logistic regression provides a robust tool for predicting carotid atherosclerosis risk in hypertensive patients.
Nomogram may aid CAS risk stratification in hypertension; hypothesis-generating until externally validated.
Background and objectives: Carotid atherosclerosis (CAS) is increasingly prevalent among hypertensive patients. This study aims to develop a predictive nomogram for CAS in hypertensive population. Methods: A total of 930 patients with hypertension were hospitalized in the Department of Cardiology of the Affiliated Hospital of Changzhou, Nanjing University of Chinese Medicine (August 2018-August 2024) formed the development cohort, categorized into CAS (156 individuals) and non-CAS (774 individuals) groups. Additionally, 398 hypertensive patients from the Department of Cardiology of the Second Affiliated Hospital of Soochow University served as the validation cohort (ratio 7:3), with 72 CAS individuals and 326 non-CAS individuals. LASSO regression initially identified key risk factors, followed by logistic regression for further analysis. The nomogram, constructed using the "rms" package in R 4.2.6, underwent internal validation via the 1,000 iterations of Bootstrap resampling. Model performance was evaluated through ROC curves, calibration curves, and decision curve analysis. Results: < 0.05), among which DM was the most important influencing factor. The nomogram demonstrated strong predictive accuracy, with AUC values of 0.858 [95% CI (0.798, 0.918)] in the development cohort and 0.808 [95% CI (0.740, 0.876)] in the validation cohort. Calibration curves closely aligned with the ideal model, and decision curve analysis indicated optimal predictive performance within a probability threshold range of 0.050-0.960. Conclusions: This study presents a robust nomogram for assessing CAS risk in hypertensive patients, offering a valuable tool for clinical risk evaluation.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: